tiprankstipranks
Trending News
More News >
Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
US Market

Edgewise Therapeutics (EWTX) Income Statement

Compare
413 Followers

Edgewise Therapeutics Income Statement

Last quarter (Q4 2025), Edgewise Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Edgewise Therapeutics's net income was $-50.22M. See Edgewise Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.27M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 189.14M$ 158.83M$ 114.36M$ 71.66M$ 43.22M
Depreciation and Amortization
$ 2.27M$ 2.29M$ 1.73M$ 538.00K$ 272.00K
EBITDA
$ -165.53M$ -156.54M$ -112.63M$ -71.12M$ -42.94M
Operating Income
$ -191.41M$ -158.83M$ -114.36M$ -71.66M$ -43.22M
Other Income/Expenses
$ 23.61M$ 25.02M$ 14.19M$ 4.02M$ 402.00K
Pretax Income
$ -167.79M$ -133.81M$ -100.16M$ -67.64M$ -42.81M
Net Income
$ -167.79M$ -133.81M$ -100.16M$ -67.64M$ -42.81M
Per Share Metrics
Basic EPS
$ -1.63$ -1.45$ -1.57$ -1.26$ -0.86
Diluted EPS
$ -1.63$ -1.45$ -1.57$ -1.26$ -0.86
Weighted Average Shares Outstanding
102.93M 92.41M 63.72M 53.59M 49.50M
Weighted Average Shares Outstanding (Diluted)
102.93M 92.41M 63.72M 53.59M 49.50M
Currency in USD

Edgewise Therapeutics Earnings and Revenue History